Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insmed Inc.

www.insmed.com

Latest From Insmed Inc.

Pretomanid Approval For Resistant TB: With Regulatory Flexibility Comes Usage Restrictions

US FDA's approval of the TB Alliance's pretomanid regimen for highly treatment-resistant tuberculosis comes with an LPAD designation and advisory committee-requested language to limit use.

Approvals Review Pathway

Can Real-World Evidence Be Used To Remove LPAD's Limited Population Designation?

Antibiotic sponsors wonder whether RWE would be sufficient to convert a product to full approval. Ahead of US FDA's public meeting on the LPAD guidance, industry has a number of lingering questions.

Drug Review Infectious Diseases

Finance Watch: Three New Biopharma IPOs In The US With Eight More Entering The Queue

Public Company Edition: IPO performance has been mixed in 2019, but May has been the busiest month this year. Also, Insmed leads recent follow-on offerings and Dynavax restructures.

Financing Business Strategies

Mycobacterial Disease Drug Development Needs Validated Clinical Outcome Assessment

Experts at US FDA meeting debate tweaking components of existing measures to focus on symptoms – such as cough, fatigue and dyspnea – that are most bothersome to patients with the nontuberculous form of the disease.

Clinical Trials Drug Approval Standards
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Insmed Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Insmed Inc.
  • Senior Management
  • Will Lewis, Chmn. & CEO
    Paolo Tombesi, CFO
    Roger Adsett, Chief Commercial Officer
  • Contact Info
  • Insmed Inc.
    Phone: (908) 977-9900
    10 Finderne Ave., Bldg. 10
    Bridgewater, NJ 08807-3365
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register